WO2025119332 - GENETICALLY MODIFIED NON-HUMAN ANIMAL WITH HUMAN OR CHIMERIC TL1A
National phase entry is expected:
Publication Number
WO/2025/119332
Publication Date
12.06.2025
International Application No.
PCT/CN2024/137441
International Filing Date
06.12.2024
Title **
[English]
GENETICALLY MODIFIED NON-HUMAN ANIMAL WITH HUMAN OR CHIMERIC TL1A
[French]
ANIMAL NON HUMAIN GÉNÉTIQUEMENT MODIFIÉ PORTANT UN GÈNE TL1A HUMAIN OU CHIMÉRIQUE
Applicants **
BIOCYTOGEN PHARMACEUTICALS (BEIJING) CO., LTD.
Inventors
LI, Chong
ZHANG, Zhi
ZHANG, Shujin
Priority Data
202311667117.0
07.12.2023
CN
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| Number of Office Actions | * |
| * | |
International Searching Authority |
CNIPA
* |
| Recordal of a Change of the Applicant's Name/Address |
Change of Applicant's Name and Address
* |
| Type of Assignment |
The Standard Agent's Assignment
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Patent Delivery |
Send the Letters Patent by Courier
* |
| Translation |
|
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing, Examination, Granting | 3670 | |
| EPO | Filing, Examination, Granting | 55035 | |
| Japan | Filing, Examination, Granting | 3817 | |
| South Korea | Filing, Examination, Granting | 5725 | |
| USA | Filing, Examination, Granting | 22940 |
Total:
91,187
The term for entry into the National Phase has expired. This quotation is for informational purposes only
Contact Us
Abstract[English]
Provided are genetically modified non-human animals that express a human or chimeric (e.g., humanized) TIL1A, and methods of use thereof.[French]
La présente invention concerne des animaux non humains génétiquement modifiés exprimant une TIL1A humaine ou chimérique (par exemple humanisée), ainsi que des procédés d'utilisation associés.